What is the future of pharmacogenomics in pain management?

Pharmacogenomics. 2017 Jan;18(2):101-103. doi: 10.2217/pgs-2016-0173. Epub 2016 Dec 19.

Authors

Ana M Peiró^{1

2}, César Margarit^{2

3}, Adrián LLerena⁴

Affiliations

¹ Clinical Pharmacology Unit, Department of Health of Alicante, General Hospital, Alicante, Spain.
² Neuropharmacology on Pain & Functional Diversity (NED), Research Unit, Department of Health of Alicante, General Hospital, ISABIAL, Alicante, Spain.
³ Pain Unit, Department of Health of Alicante, General Hospital, Alicante, Spain.
⁴ CICAB Clinical Research Centre, Extremadura University Hospital & Medical School, Badajoz, Spain.

PMID: 27992298
DOI: 10.2217/pgs-2016-0173

No abstract available

Keywords: chronic pain; clinical translation; guidelines; pharmacogenomics.

MeSH terms

Chronic Pain / drug therapy
Chronic Pain / genetics*
Humans
Pain Management / methods
Pharmacogenetics / methods
Polymorphism, Single Nucleotide / genetics
Quality of Life